Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
190.95Prev. Close
190.38Volume
8,99,879Total traded value
16.81 CrUpper Circuit
224.14Lower Circuit
149.43Fundamentals
| Market Cap | ₹8,631Cr |
| ROE | 15.43% |
| P/E Ratio(TTM) | 24.54 |
| EPS(TTM) | 7.76 |
| P/B Ratio | 3.50 |
| Dividend Yield | 0.42% |
| Industry P/E | 34.63 |
| Book Value | 54.44 |
| Debt to Equity | 0.13 |
| Face Value | 1 |
Understand Fundamentals
Financials
About Marksans Pharma
Marksans Pharma is a trusted global pharmaceutical company that develops, manufactures, and distributes both over-the-counter (OTC) and prescription (Rx) drugs for regulated markets. Its guiding vision is to transform into a respected, profitable, and integrated global pharmaceutical enterprise by delivering quality formulations to people. The company's overall manufacturing capacity has impressively reached 26 billion units per year, a fourfold increase achieved over several years.;
| Parent Organisation | Marksans Pharma Limited |
| Managing Director | Mr. Mark Saldanha |
| NSE Symbol | MARKSANS |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Top Mutual Funds Invested(4)
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 61.33 | ||
| Gland Pharma | NA (0.00%) | 42.19 | ||
| Ajanta Pharma | NA (0.00%) | 32.58 | ||
| Eris Lifesciences | NA (0.00%) | 52.95 |